As you may be aware, the IBD Registry is delighted to be working with 16 other organisations to transform IBD care and outcomes in the UK as part of IBD UK. IBD UK launched in 2019 the revised IBD Service Standards, the organisational element of the full Inflammatory Bowel Disease (IBD) Audit, as a complement to the Registry’s rolling IBD Biological Therapies Audit, providing the clinical audit element.
The IBD Service Standards are assessed by the IBD Benchmarking Tool, which allows a service to benchmark its performance against the 2019 IBD Standards, supported by an IBD UK Patient Survey.
The IBD UK Patient Survey has now closed, with over 10,000 surveys completed, and 88% of IBD clinical teams across the UK have already registered for the IBD Benchmarking Tool.
The vision is that together these assessments will allow services to identify what is working well and where their service can be improved.
The deadline for the first IBD Benchmarking self-assessment has been extended to 31st January 2020.
We’d really like to encourage all IBD teams to complete their self-assessments before this date, when the self-assessment closes. Please spread the word and help improve outcomes for patients.
There’s lots of guidance and tips on the IBD UK website and a useful blog from services that have completed the process
The results of both the IBD Benchmarking Tool and the IBD Biological Therapies Audit will be available in March 2020, and able to inform business cases and targeted plans for quality improvement.
Following this, national reports will be produced, giving an overall picture of IBD care across the UK.
If you would like any more information on the IBD Benchmarking Tool and IBD Standards, please visit www.ibduk.org or e: email@example.com; for the Clinical Audit, please visit this page on our site: https://ibdregistry.org.uk/qualityaccounts/
The Inflammatory Bowel Disease (IBD) Audit, provided by the IBD Registry, has been listed on Quality Accounts since 2016.
For 2019-20 we are pleased to complement the Registry’s rolling clinical audit with the new IBD Service Standards workstream.
Trusts are encouraged to fully participate in Quality Accounts by submitting both clinical and organisational data from the two complementary workstreams.
More information on Quality and Standards is also available on this site at https://ibdregistry.org.uk/quality-standards/
Contact us at firstname.lastname@example.org for more information.
Find out more about:
The UK governments have introduced a relaxation of shielding measures for high risk people, although you may be asked to shield again if there's an outbreak in your local area. The shielding scheme in England, Northern Ireland and Scotland paused from 31 July 2020,...
We are delighted to report that the Registry now holds a total of 67,870 records, following a marvellous submission effort from teams in July with an increase of 4,689 from 56 clinical teams – a remarkable achievement given the pressure on IBD services currently....
In response to “significantly falling” infection rates, the Government has announced changes to “shielding” guidance in England and Wales. The government has already eased restrictions in early July, in the lead up to a pause in the programme from the 1st August 2020,...
Important information for Registry-participating clinical teams: with the COVID-19 outbreak, to ease pressure on clinical teams we postponed the last (April) submission deadline. The next submission deadline is 10 July 2020 for data to the end of June, including all...
Over 32,000 people in the UK with IBD have self-assessed their risk since launch on the 1 April 2020. Between them, they have identified the 175 hospitals (Trusts and Health Boards) that provide them with care, and the data has been shared back to their doctors which...